Product Information
- KR- 334944-(2-(4-Bromophenylthio)·acetamido)·-·1-·phenethyl-·1H-·pyrazole-·3-·carboxylic acid
KR-334 is a small molecule that has been shown to have neuroprotective effects in rats with Parkinson's disease. It is a member of the annexin family and binds to a specific site on the surface of dopaminergic neurons, which may be involved in the death pathway. KR-334 can also inhibit neuronal cell death by inhibiting apoptosis. The most notable effect is an increase in striatal dopamine levels, which has been demonstrated using immunofluorescence and serum biochemistry tests. This drug also activates dopaminergic neurons by increasing the number of dopamine receptors on their surface. KR-334 has been shown to be effective in animal models and should be tested for treatment of human patients with Parkinson's disease.
Chemical properties
Technical inquiry about: 3D-FB158572 KR- 33494
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
